Below are 10 news articles from the past 7 days regarding COVID-19 to help guide you in making your decision. Using your best judgement, take into consideration only the articles that are most relevant for forecasting COVID-19 hospitalizations in Ontario, Canada. Articles that are from know reputable sources have been flagged with "Trusted: True".

Article 1 of 10
Title: Therapeutic Management of Residents of Long-term Care Homes with COVID-19
Publisher: Ontario COVID-19 Science Advisory Table
Trusted: True
Posted: 1 day ago
This document appears to be a citation for a scientific paper titled "Therapeutic Management of Residents of Long-term Care Homes with COVID-19", produced by the Ontario COVID-19 Science Advisory Table and various working groups. Unfortunately, I do not have access to the full paper and can only provide information from the citation provided. The citation includes important metadata about the paper, such as the authors, affiliations, declarations of interest, and copyright information. It also provides a link to the paper, which can be accessed through the DOI (Digital Object Identifier). The paper seems to focus on the therapeutic management of COVID-19 residents in long-term care homes, which may include information on hospitalization rates and strategies to manage the virus within these homes.

Article 2 of 10
Title: Ontario Newsroom
Publisher: Government of Ontario News
Trusted: True
Posted: 1 day ago

Article 3 of 10
Title: COVID-19 Vaccines
Publisher: The Canadian Encyclopedia
Trusted: False
Posted: 1 day ago
Here is a summary of the article: The development of COVID-19 vaccines was unprecedented in terms of the level of international cooperation and government funding. The public sharing of the SARS-CoV-2 virus genetic sequence in January 2020 accelerated vaccine research and development, with many countries and organizations collaborating. This led to the creation of the Access to COVID-19 Tools (ACT) Accelerator and the US government's Operation Warp Speed initiative, which expedited vaccine development and distribution. Typically, vaccine development takes 10-15 years, including clinical trials and regulatory approval. However, due to the urgency of the pandemic, processes were run in parallel to shorten the timeline without compromising safety. Multiple approaches were taken in developing COVID-19 vaccines, including inactivated virus methods, viral vector methods, and the ultimately successful messenger RNA (mRNA) technology. mRNA vaccines work by delivering molecules of antigen-encoding mRNA into immune cells, stimulating an adaptive immune response that teaches the body to recognize and destroy the pathogen. The foundation for this technology was laid by decades of research, including important contributions from Canadian and American universities. The rapid spread of the pandemic accelerated mRNA-based vaccine development at companies like Moderna and Pfizer-BioNTech. Clinical trials demonstrated high safety levels and remarkable efficacy, leading to emergency use authorization in several countries by December 2020. As of March 2023, there are 50 COVID-19 vaccines authorized for public use globally, and Canada has achieved one of the highest vaccine uptake levels internationally, with 83.4% of its total population receiving at least one dose. However, vaccine uptake varies widely across the world, with many countries, especially in Africa, facing challenges such as distribution and public resistance. The development and deployment of safe and effective COVID-19 vaccines amid an unprecedented pandemic are considered a remarkable and historic achievement.

Article 4 of 10
Title: Tracking Social Determinants of Health During the COVID-19 Pandemic
Publisher: KFF
Trusted: False
Posted: 2 days ago
Here is a summary of the article: The COVID-19 pandemic has had significant public health and economic impacts in the United States, with millions losing jobs or income and struggling to meet basic needs. The Census Bureau's Household Pulse Survey tracks how people's lives have been affected by the pandemic through social determinants of health, which include factors like socioeconomic status, education, and access to healthcare. As of March 2-14, 2022, the survey reveals that: 13.6% of adults reported a loss of employment income in their household in the past four weeks. 61.3% of adults had difficulty paying for household expenses in the past 7 days, with 31.8% using credit cards or loans. 7% of adults had no confidence in their ability to pay next month's housing costs, and 10.3% experienced food insufficiency. 31.4% of adults exhibited symptoms of depression or anxiety. Racial disparities persist, with Black and Hispanic adults faring worse than White adults across most measures. The pandemic's effects on social determinants of health have been long-lasting, with peaks in certain hardships in December 2020 but overall stability since then. Federal legislation has provided financial support, but the pandemic's trajectory remains uncertain with new variants and surges. Key points to watch include the impact of federal funding, the potential for broader legislative proposals to address health coverage and disparities, and the ongoing challenges faced by specific demographic groups. The data highlights the ongoing struggle of many Americans in meeting basic needs and maintaining their health and well-being during the pandemic.

Article 5 of 10
Title: Ontario reports 207 patients in ICU with COVID-19 — a new 6th wave high
Publisher: CBC News
Trusted: False
Posted: 2 days ago
Here is a summary of the article: The number of COVID-19 patients in Ontario's ICUs rose slightly on Thursday, with 207 people in intensive care, a new high for the sixth wave. The Ministry of Health also reported 5,038 new cases, but this included a "data catch up" of unspecified timeframe and proportion. The seven-day average of daily cases was 2,869, though limited laboratory testing may affect accuracy. There are 1,626 people hospitalized with COVID-19, with roughly 45% admitted due to virus symptoms. Health Minister Christine Elliott stated that hospitalizations are expected to decline as the current wave has likely crested, and the government has no plans to reinstate a mask mandate in schools. Education Minister Stephen Lecce supported this decision, emphasizing that medical officers will guide pandemic decisions. The health ministry also reported 17 additional deaths, bringing Ontario's total to 12,678. Over 39,000 vaccine doses were administered on Wednesday, mostly as second boosters for those 60+. Over 87% of eligible Ontarians have received at least two vaccine doses.

Article 6 of 10
Title: Intramuscular AZD7442 (Tixagevimab–Cilgavimab) for Prevention of Covid-19
Publisher: nejm.org
Trusted: False
Posted: 3 days ago

Article 7 of 10
Title: Accelerating COVID-19 Vaccine Deployment
Publisher: World Health Organization (WHO)
Trusted: True
Posted: 3 days ago
The G20 Finance Ministers and Central Bank Governors met in February 2022 to discuss the ongoing COVID-19 pandemic. They requested a report on strategies to increase COVID-19 vaccination rates and identify obstacles to vaccine deployment. The report was prepared with support from six international bodies and led by the COVID-19 Vaccine Delivery Partnership and ACT-Accelerator Hub. The World Health Organization (WHO) and the World Bank collaborated with the International Monetary Fund (IMF), World Trade Organization (WTO), Gavi, and UNICEF to produce the report. The goal is to accelerate vaccine deployment and address any barriers to getting more vaccines to people, which is crucial for forecasting and managing COVID-19 hospitalizations.

Article 8 of 10
Title: Accelerated biological aging in COVID-19 patients
Publisher: Nature.com
Trusted: False
Posted: 4 days ago
This study investigates the link between epigenetic aging, telomere length, and the severity of COVID-19 outcomes. The key findings are as follows: Epigenetic clocks and telomere length analysis revealed a correlation between accelerated epigenetic aging and the risk of SARS-CoV-2 infection and the development of severe COVID-19. COVID-19 can influence the epigenetic clock, causing telomere shortening and accelerating epigenetic aging, which may contribute to long COVID symptoms. Accelerated epigenetic aging could potentially serve as a biomarker to predict severe COVID-19 cases that require hospitalization and increased mortality. The influence of COVID-19 on epigenetic aging can be reversed in some patients, indicating the potential for recovery from long COVID symptoms. The study has limitations, including a small sample size and the need for further research to establish a causal relationship between COVID-19 and accelerated epigenetic aging. In summary, this research suggests that epigenetic aging may play a role in forecasting COVID-19 hospitalizations by identifying patients at high risk of developing severe COVID-19 and long COVID symptoms.

Article 9 of 10
Title: University of Victoria
Publisher: University of Victoria
Trusted: False
Posted: 4 days ago
UVic researchers have developed a new test for COVID-19 that can detect and quantify the virus with high accuracy using only a small blood sample. The test measures the levels of the SARS-CoV-2 virus nucleoprotein, which is less prone to mutations compared to spike proteins, allowing the detection of new variants. This test provides valuable information on disease progression and severity, and can also be used with nasal swabs and saliva samples. The technology behind the test, called SISCAPA, can detect and quantify multiple protein biomarkers, making it applicable to other infectious and non-infectious diseases. The development of this test was a collaboration between UVic microbiologist Caroline Cameron and SISCAPA Assay Technologies Inc., with support from an NSERC COVID-19 Alliance Grant. The test has been shared with research partners in Europe and North America, and a commercial kit based on the assay is now available worldwide. This innovative test has the potential to revolutionize clinical laboratory testing and improve our understanding of COVID-19 and other diseases.

Article 10 of 10
Title: New COVID-19 breath test approved in U.S. Here’s how it could be useful - National
Publisher: Global News
Trusted: False
Posted: 7 days ago
A new COVID-19 screening tool, the InspectIR COVID-19 Breathalyzer, has been authorized for emergency use by the FDA and could make testing faster and more accessible. The breath test is more accurate than rapid antigen tests with a sensitivity of 91%. It is also non-invasive, which may encourage more people to get tested. The test can be performed in about 10 seconds by exhaling into a tube or straw connected to the testing kit, with results available in about three minutes. This test could be useful in settings like schools and long-term care homes, reducing transmission rates. However, it may be influenced by factors like recent meals and does not provide details on specific variants. The cost and level of training required to operate the test are currently unclear.